Efflumidex en es it fr

Efflumidex Brand names, Efflumidex Analogs

Efflumidex Brand Names Mixture

  • L-S 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Sulfate))
  • Lincomycin Spectinomycin 100 Soluble Powder (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))
  • Lincomycin Spectinomycin 4.4% G Premix (Lincomycin (Lincomycin Hydrochloride) + Spectinomycin (Spectinomycin Hydrochloride))

Efflumidex Chemical_Formula


Efflumidex RX_link


Efflumidex fda sheet

Efflumidex FDA

Efflumidex msds (material safety sheet)

Efflumidex MSDS

Efflumidex Synthesis Reference

No information avaliable

Efflumidex Molecular Weight

376.462 g/mol

Efflumidex Melting Point

297 oC

Efflumidex H2O Solubility

30 mg/L

Efflumidex State


Efflumidex LogP


Efflumidex Dosage Forms

Drops; Suspension

Efflumidex Indication

A topical anti-inflammatory product for ophthalmic use. For the treatment of corticosteroid-responsive inflammation of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe

Efflumidex Pharmacology

No information avaliable

Efflumidex Absorption

No information avaliable

Efflumidex side effects and Toxicity

Side effects may include acute anterior uveitis and perforation of the globe. Keratitis, conjunctivitis, corneal ulcers, mydriasis, conjunctival hyperemia, loss of accommodation and ptosis have occasionally been reported following local use of corticosteroids. LD50 = 234 mg/kg (rats)

Efflumidex Patient Information

Efflumidex Organisms Affected

Humans and other mammals